DP3 Type 1 Diabetes Targeted Research Award
Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
The National Institute of Diabetes and Digestive and Kidney Diseases seeks to accelerate the pace of scientific research towards prevention, more effective treatment, or cure of type 1 diabetes and its complications. To this end, NIDDK is committed to providing access to research resources which will increase our understanding of type 1 diabetes pathogenesis, and pathogenesis of its complications, in humans. This opportunity is intended to fund projects using subjects who have been phenotypically and genetically characterized for risk of developing type 1 diabetes through the Type 1 Diabetes TrialNet Pathway To Prevention clinical research network, and projects using subjects currently enrolled and followed for diabetic complications in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC). To assist applicants for this and other related funding opportunity announcements, two webinars are planned. Applicants should visit the NIDDK website
for more information about registering for one of these informational webinars.
For examples of projects funded under similar FOAs, use the NIH Research Portfolio Online Reporting Tool (RePORTER
). Enter the FOA designations (PAR-13-028 or PAR-11-349 or PAR-14-064, separate queries) in the field labeled FOA in the "Project Details" section, clear the Fiscal Years field in the top right corner of the query page, and run the query to view descriptions of awarded grants.
|Notice(s) for this Opportunity|
|Letter of Intent Due Date|
|Application Due Date|
November 20, 2014, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.